Casdin Capital, LLC Maxcyte, Inc. Transaction History

Casdin Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$3.02 - $5.1 $8.53 Million - $14.4 Million	-2,825,000 Reduced 59.92%	1,890,000 $5.9 Million
Q2 2023 Aug 14, 2023	SELL	$3.69 - $5.35 $774,900 - $1.12 Million	-210,000 Reduced 4.26%	4,715,000 $21.6 Million
Q1 2023 May 15, 2023	SELL	$4.03 - $5.89 $18.5 Million - $27 Million	-4,580,000 Reduced 48.19%	4,925,000 $24.4 Million
Q4 2022 Feb 14, 2023	SELL	$4.92 - $7.4 $6.06 Million - $9.11 Million	-1,230,786 Reduced 11.46%	9,505,000 $51.9 Million
Q3 2022 Nov 14, 2022	SELL	$4.52 - $6.51 $14.6 Million - $21.1 Million	-3,235,548 Reduced 23.16%	10,735,786 $69.8 Million
Q3 2021 Nov 15, 2021	BUY	$12.21 - $17.2 $171 Million - $240 Million	13,971,334 New	13,971,334 $171 Million

118

65M

600

2.7K

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $368M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.